Perceptive Advisors’s Dova Pharmaceuticals, Inc. Common Stock DOVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-3,708,705
| Closed | -$104M | – | 135 |
|
|
2019
Q3 | $104M | Buy |
3,708,705
+155,645
| +4% | +$4.35M | 2.79% | 10 |
|
|
2019
Q2 | $50.1M | Buy |
3,553,060
+427,209
| +14% | +$6.02M | 1.15% | 21 |
|
|
2019
Q1 | $27.8M | Hold |
3,125,851
| – | – | 0.78% | 33 |
|
|
2018
Q4 | $23.7M | Hold |
3,125,851
| – | – | 0.9% | 31 |
|
|
2018
Q3 | $65.5M | Hold |
3,125,851
| – | – | 1.75% | 16 |
|
|
2018
Q2 | $93.5M | Buy |
3,125,851
+344,874
| +12% | +$10.3M | 2.45% | 9 |
|
|
2018
Q1 | $75.4M | Buy |
2,780,977
+971,962
| +54% | +$26.4M | 2.11% | 11 |
|
|
2017
Q4 | $52.1M | Buy |
1,809,015
+55,000
| +3% | +$1.58M | 1.73% | 15 |
|
|
2017
Q3 | $42.6M | Buy |
1,754,015
+47,516
| +3% | +$1.15M | 1.63% | 14 |
|
|
2017
Q2 | $38M | Buy |
+1,706,499
| New | +$38M | 1.91% | 13 |
|